uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted April 17, 2012

FDA Warns Seller of Diabetes Supplement Marketed with Rx Claims

The FDA has posted a Warning Letter (dated April 4, 2012) to Leaner Living regarding the marketing of its Glycosolve product. Although sold as a supplement, Glycosolve is being promoted for use in the cure, mitigation, treatment, or prevention of diseases such as diabetes and elevated cholesterol, making the product an unapproved drug.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at